It has been proved that AGEs could induce tau hyperphosphorylation through RAGEs-GSK3β signaling activation [311], and direct AGEs injection in mice brain displayed AD pathological features, such as decreased memory and increased tau phosphorylation, APP expression, and Aβ42 formation [312,313]. The gene discussed is APP; the disease is Alzheimer disease.